Tech Company Inital Public Offerings
Spruce Biosciences IPO
Spruce Biosciences, operating out of San Francisco, had an IPO event on 10/8/2020.
Transaction Overview
Company Name
Announced On
10/8/2020
Transaction Type
IPO
Amount
$90,000,000
Proceeds Purpose
Management says it will use the net proceeds from the IPO as follows:approximately $5.0 million to fund our two Phase 2b clinical trials of tildacerfont in adult patients with classic CAH;approximately $20.0 million to fund NDA enabling and commercial readiness activities to market tildacerfont for adults with classic CAH in the United States and Europe, if approved;approximately $40.0 million to fund our research and development efforts for tildacerfont in children with classic CAH and other rare endocrine disorders, including in a subpopulation of females with a rare form of PCOS; andany remaining proceeds for working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1700 Montgomery St. 212
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Undisclosed
Website
Email Address
Overview
Spruce Biosciences (Nasdaq: SPRB) is a clinical-stage biopharmaceutical based in San Francisco, California. Our mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis (the stress pathway).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard King
Chief Medical Officer
Kamal Bharucha
Chief Medical Officer
Michael Huang
Vice President
Chris Barnes
VP - Manufacturing
Sangita Ghosh
VP - Operations
David Moriarty
VP - Regulatory Affairs
Marc Lesnick
Browse more venture capital transactions:
Prev: 10/8/2020: Shogun venture capital transaction
Next: 10/8/2020: Redaptive venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs